Trademark Search in Canada

PINPOINT

View On IC.GC.CA

REGISTERED

on 20 Sept 2023

Last Applicant/ Owned by

HORIZON DISCOVERY LIMITED

8100 Cambridge Research Park,Waterbeach Cambridge CB25 9TL

Serial Number

2046807 filed on 11^th Jun 2020

Registration Number

TMA1198520 registered on 20^th Sept 2023

Registration expiry Date

11^th Jun 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

SUITE 6200, P.O. BOX 501 FIRST CANADIAN PLACETORONTO

ONTARIO

M5X1B8

PINPOINT

Trademark usage description

biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering Read More

Classification Information

Class [001]
Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; antibody reagents, blood grouping reagents, cell culture reagents, chemical reagents, diagnostic reagents, plasmids, laboratory assays and biochemical assays for use in scientific, genetic and medical research; genomic reference control samples for medical laboratory use; chemical reagents, biological reagents and biochemical reagents for use in molecular biology research; biological preparations namely, separate base (genome) editing components, namely, mRNA, rRNA, gRNA, deaminase (enzymes), nickase (enzymes), ribonucleotide protein (RNP) for use in scientific, laboratory and medical research; biological preparations, namely, genetically modified prokaryotic and eukaryotic cells, and viral vectors for scientific and research purposes; biological and chemical reagents and complexes of the aforesaid goods for use in medical and scientific research and for clinical and commercial use in the fields of cell and gene therapies

Classification kind code

Class [005]
Diagnostic preparations and materials generated by the use of base editing components, namely clinical diagnostic reagents, diagnostic chemical reagents for medical purposes, diagnostic preparations for clinical laboratory use, diagnostic preparations for medical laboratory use, diagnostic reagents for clinical laboratory use, diagnostic reagents for medical use; chemical preparations for use in DNA analysis (medical); DNA, RNA and parts thereof; DNA extracts; DNA reference standards; DNA reference libraries being collections of DNA and gene sequences; gene editing enzymes; protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological, biochemical and chemical reagents, namely, modified prokaryotic and eukaryotic cells, genetically modified stem cells and viral vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids and complexes of the aforesaid for medical and commercial use, all the aforesaid goods being medical preparations

Classification kind code

Class [040]
Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services in the field of biopharmaceutical and manufacture of cells and vectors for diagnostic, medical and commercial applications for cell and gene therapies

Classification kind code

Class [042]
Custom cell-line engineering services; base-editing services; gene engineering services; research and development services namely, creation of libraries or collections of biological tissues, cells and cell lines; creating libraries or collections of normal and mutated genes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of research studies in the field of gene editing; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services in the field of biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies

Classification kind code

Mark Details

Serial Number

2046807

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 13^th Apr 2022	Agent Changed
Submitted for opposition 22 on 13^th Dec 2021	Search Recorded
Submitted for opposition 20 on 13^th Dec 2021	Examiner's First Report
Submitted for opposition 223 on 13^th Dec 2021	Total Provisional Refusal
Submitted for opposition 256 on 21^st Jun 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 20^th Aug 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 20^th Aug 2020	Formalized
Submitted for opposition 1 on 20^th Aug 2020	Created
Submitted for opposition 228 on 11^th Jun 2020	International Registration
Submitted for opposition 30 on 11^th Jun 2020	Filed